Page last updated: 2024-09-05

tinuvin 770 and Atherosclerotic Parkinsonism

tinuvin 770 has been researched along with Atherosclerotic Parkinsonism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfahel-Kakunda, A; Herishanu, Y; Masalha, R; Silverman, WF1
Jackson-Lewis, V; Liberatore, G1

Other Studies

2 other study(ies) available for tinuvin 770 and Atherosclerotic Parkinsonism

ArticleYear
Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease?
    Brain research, 1997, Nov-07, Volume: 774, Issue:1-2

    Topics: Animals; Decanoic Acids; Dopamine; Dose-Response Relationship, Drug; Environmental Pollutants; Fetus; Industry; Mesencephalon; Neurons; Parkinson Disease, Secondary; Piperidines; Rats

1997
Effects of a unilateral stereotaxic injection of Tinuvin 123 into the substantia nigra on the nigrostriatal dopaminergic pathway in the rat.
    Brain research, 2000, Jun-02, Volume: 866, Issue:1-2

    Topics: Animals; Astrocytes; Behavior, Animal; Calcium Channel Blockers; Decanoic Acids; Dopamine; Environmental Pollutants; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Male; Movement; Neostriatum; Nerve Degeneration; Neural Pathways; Neurons; Neurotoxins; Occupational Exposure; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Survival Rate; Tyrosine 3-Monooxygenase

2000